Abstract
Background Ovarian cancer (OC) responds poorly to immunotherapies. Regulatory T cells (Treg) engage IL-2 by high-affinity CD25 for differentiation and function,1 and anti-tumor effector T cells (Teff) use intermediate affinity...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have